Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBD<sub>N318-V510</sub>) Expressed in <i>Escherichia coli</i>

Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBD<sub>N318-V510</sub>) Expressed in <i>Escherichia coli</i>

Massive worldwide serological testing for SARS-CoV-2 is needed to determine the extent of virus exposure in a particular region, the ratio of symptomatic to asymptomatic infected persons, and the duration and extent of immunity after infection. To achieve this, the development and production of reli...

Full description

Bibliographic Details
Main Authors: Alan Roberto Márquez-Ipiña, Everardo González-González, Iram Pablo Rodríguez-Sánchez, Itzel Montserrat Lara-Mayorga, Luis Alberto Mejía-Manzano, Mónica Gabriela Sánchez-Salazar, José Guillermo González-Valdez, Rocio Ortiz-López, Augusto Rojas-Martínez, Grissel Trujillo-de Santiago, Mario Moisés Alvarez
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Diagnostics
Subjects:
SARS-CoV-2
COVID-19
ELISA
serological testing
spike
receptor binding domain
Online Access:https://www.mdpi.com/2075-4418/11/2/271

Internet

https://www.mdpi.com/2075-4418/11/2/271

Similar Items